Home - Products - GPCR/G Protein - LPA Receptor - 1-Oleoyl lysophosphatidic acid sodium salt

1-Oleoyl lysophosphatidic acid sodium salt

CAS No. 325465-93-8

1-Oleoyl lysophosphatidic acid sodium salt( —— )

Catalog No. M22396 CAS No. 325465-93-8

1-Oleoyl lysophosphatidic acid sodium salt is an Endogenous agonist of LPA1 and LPA2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 140 In Stock
10MG 164 In Stock
25MG 329 In Stock
50MG 494 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Oleoyl lysophosphatidic acid sodium salt
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Oleoyl lysophosphatidic acid sodium salt is an Endogenous agonist of LPA1 and LPA2.
  • Description
    1-Oleoyl lysophosphatidic acid sodium salt is an Endogenous agonist of LPA1 and LPA2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    LPA Receptor
  • Recptor
    LPA1|LPA2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    325465-93-8
  • Formula Weight
    458.5
  • Molecular Formula
    C21H40NaO7P
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 100 mg/mL (218.10 mM)
  • SMILES
    [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BMS-986278

    BMS-986278 is an orally active and potent hemophosphatidic acid receptor 1 (LPA1) antagonist with Kb values of 6.9 nM and 4.0 nM for human and mouse LPA1, respectively.

  • Radioprotectin-1

    Radioprotectin-1 is a selective agonist of LPA2 with EC50 of 25 nM for murine LPA2 GPCR and exerts radioprotective and radiomitigative action.

  • Ki16198

    Ki16198 is the methyl ester of Ki16425 which is a LPA antagonist and inhibits LPA1- and LPA3-induced inositol phosphate production with Ki of 0.34 μM and 0.93 μM.